Optimal Multimodal Analgesia in Laparoscopic Cholecystectomy
NCT ID: NCT00209885
Last Updated: 2005-09-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
60 participants
INTERVENTIONAL
2005-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* A: standard of care (SOC)receiving intraoperative dexamethasone, ondansetron, ketorolac, and general anaesthesia with propofol, remifentanil and cisatracurium
* B: SOC + preoperative gabapentin, intraoperative lidocain infusion, s-ketamin and droperidol.
Primary endpoints:
* postoperative abilities over time
* discharge time from PACU according to fixed criteria
* consumption of analgesics and antiemetics in the PACU
Secondary endpoints:
* degree of nursing requirements at the PACU
* General tolerability of the regimes
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Gabapentin
S-ketamine
Lidocaine
Droperidol
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age above 18 years
* Written informed consent
* ASA class I-III
Exclusion Criteria
* Intraoperative conversion of laparoscopic to laparotomic cholecystectomy
* Allergy to part of the treatment regimens
* Previous reactions to opioids (nausea, cognition)
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hvidovre University Hospital
OTHER
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kenneth Jensen, M.D.
Role: PRINCIPAL_INVESTIGATOR
Dept of Anaesthesia, Acute Pain Service, Hvidovre Hospital, Copenhagen, Denmark
Claus Lund, dr.med.sci
Role: STUDY_CHAIR
Dept of Anaesthesia, Hvidovre Hospital, Copenhagen, Denmark
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept of Anaesthesia, Hvidovre Hospital
Copenhagen, Hvidovre, Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Kenneth Jensen, M.D.
Role: primary
Related Links
Access external resources that provide additional context or updates about the study.
URL looking into anaesthesia and surgery for cholecystectomy
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OMA-LC01
Identifier Type: -
Identifier Source: org_study_id